Celldex brings out the ax in wake of breast cancer drug disaster, chopping a quarter of its...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 25, 2018 at 9:52 AM.

  1. #1 cafead, Apr 25, 2018 at 9:52 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Celldex Therapeutics $CLDX is restructuring and cutting back in the aftermath of a disastrous Phase IIb readout. The company — no stranger to misfortune — reported late Thursday that it is cutting 59 positions from its 2018 budgeted workforce, leaving it with 148 employees.

    article source
     
    Quote

Reply to Thread